The complex interaction between dengue viruses and the human immune system means that development of a safe, effective dengue vaccine was never going to be simple. The only currently licenced dengue vaccine (Dengvaxia®) does, indeed, have a complex immune profile depending on recipients’ immune status, meaning that use of this vaccine is not straightforward. This commentary reviews the recommendations for vaccine use to date, and discusses issues and opportunities related to the implementatio...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's Version
- Oxford University Press Publisher's website
- Transactions of The Royal Society of Tropical Medicine and Hygiene Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Clapham and Wills
- Copyright date:
© The Authors 2018. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Implementing a dengue vaccination programme - who, where and how?
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record